CRMMX
Price
$21.39
Change
-$0.17 (-0.79%)
Updated
Jul 11 closing price
Net Assets
310.42M
FSMAX
Price
$94.35
Change
-$1.02 (-1.07%)
Updated
Jul 11 closing price
Net Assets
39.17B
Interact to see
Advertisement

CRMMX vs FSMAX

Header iconCRMMX vs FSMAX Comparison
Open Charts CRMMX vs FSMAXBanner chart's image
CRM Mid Cap Value I
Price$21.39
Change-$0.17 (-0.79%)
VolumeN/A
Net Assets310.42M
Fidelity Extended Market Index
Price$94.35
Change-$1.02 (-1.07%)
VolumeN/A
Net Assets39.17B
CRMMX vs FSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CRMMX vs. FSMAX commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMMX is a Buy and FSMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.2B vs. CRMMX (310M). FSMAX pays higher dividends than CRMMX: FSMAX (0.47) vs CRMMX (0.07). CRMMX was incepted earlier than FSMAX: CRMMX (25 years) vs FSMAX (14 years). CRMMX (1.17) is less costly to investors than FSMAX (0.04). CRMMX is a more actively managed with annual turnover of: 47.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than CRMMX: FSMAX (0) vs CRMMX (2500). FSMAX annual gain was more profitable for investors over the last year : 14.64 vs. CRMMX (-5.54). FSMAX return over 5 years is better than : 61.12 vs. CRMMX (23.41).
CRMMXFSMAXCRMMX / FSMAX
Total Expense Ratio1.170.043,343%
Annual Report Gross Expense Ratio1.170.043,343%
Fund Existence25 years14 years-
Gain YTD1.2213.81832%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets310M39.2B1%
Annual Yield % from dividends0.070.4715%
Returns for 1 year-5.5414.64-38%
Returns for 3 years3.8453.307%
Returns for 5 years23.4161.1238%
Returns for 10 years-21.2376.71-28%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGI0.93N/A
N/A
Birks Group
REGCP23.60-0.04
-0.17%
Regency Centers Corp
AQST4.01-0.02
-0.50%
Aquestive Therapeutics
IMCR35.02-0.43
-1.21%
Immunocore Holdings plc
QRVO88.23-2.09
-2.31%
Qorvo